Cidel Asset Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.96M | Sell |
38,234
-1,331
| -3% | -$119K | 0.19% | 85 |
|
|
2026
Q1 | $2.84M | Buy |
39,565
+5,467
| +16% | +$421K | 0.16% | 86 |
|
|
2025
Q4 | $2.71M | Sell |
34,098
-785
| -2% | -$61.9K | 0.19% | 80 |
|
|
2025
Q3 | $2.63M | Hold |
34,883
| – | – | 0.15% | 81 |
|
|
2025
Q2 | $2.41M | Buy |
34,883
+320
| +0.9% | +$21K | 0.14% | 82 |
|
|
2025
Q1 | $2.34M | Buy |
34,563
+2,620
| +8% | +$157K | 0.15% | 80 |
|
|
2024
Q4 | $1.43M | Buy |
31,943
+2,341
| +8% | +$131K | 0.1% | 95 |
|
|
2024
Q3 | $1.86M | Buy |
29,602
+885
| +3% | +$51.6K | 0.13% | 86 |
|
|
2024
Q2 | $1.7M | Buy |
28,717
+2,791
| +11% | +$175K | 0.13% | 79 |
|
|
2024
Q1 | $2.07M | Buy |
25,926
+1,329
| +5% | +$102K | 0.16% | 79 |
|
|
2023
Q4 | $1.94M | Buy |
24,597
+20,319
| +475% | +$1.45M | 0.08% | 90 |
|
|
2023
Q3 | $299K | Sell |
4,278
-1,152
| -21% | -$81.6K | 0.01% | 123 |
|
|
2023
Q2 | $375K | Hold |
5,430
| – | – | 0.02% | 127 |
|
|
2023
Q1 | $404K | Sell |
5,430
-299,341
| -98% | -$25.1M | 0.02% | 121 |
|
|
2022
Q4 | $28.4M | Sell |
304,771
-59,608
| -16% | -$5.75M | 1.33% | 29 |
|
|
2022
Q3 | $34.8M | Sell |
364,379
-237
| -0.1% | -$23.5K | 1.65% | 20 |
|
|
2022
Q2 | $33.8M | Sell |
364,616
-26,064
| -7% | -$2.54M | 1.44% | 25 |
|
|
2022
Q1 | $39.5M | Buy |
390,680
+3,433
| +0.9% | +$361K | 1.45% | 22 |
|
|
2021
Q4 | $39.9M | Sell |
387,247
-16,427
| -4% | -$1.52M | 1.49% | 21 |
|
|
2021
Q3 | $34.3M | Sell |
403,674
-35,533
| -8% | -$2.98M | 1.4% | 24 |
|
|
2021
Q2 | $36.6M | Buy |
439,207
+22,566
| +5% | +$1.85M | 1.48% | 21 |
|
|
2021
Q1 | $31.3M | Buy |
416,641
+140,555
| +51% | +$10.2M | 1.42% | 25 |
|
|
2020
Q4 | $18.9M | Sell |
276,086
-128,090
| -32% | -$8.33M | 1.06% | 29 |
|
|
2020
Q3 | $23.6M | Buy |
404,176
+959
| +0.2% | +$59.7K | 1.34% | 32 |
|
|
2020
Q2 | $26.2M | Sell |
403,217
-57,942
| -13% | -$3.65M | 1.19% | 29 |
|
|
2020
Q1 | $27.4M | Sell |
461,159
-32,478
| -7% | -$2.17M | 1.39% | 25 |
|
|
2019
Q4 | $36.7M | Buy |
493,637
+9,875
| +2% | +$693K | 1.52% | 24 |
|
|
2019
Q3 | $30.5M | Buy |
483,762
+45,941
| +10% | +$2.72M | 1.48% | 24 |
|
|
2019
Q2 | $23.9M | Buy |
437,821
+178,111
| +69% | +$9.59M | 1.21% | 29 |
|
|
2019
Q1 | $14M | Buy |
259,710
+40,958
| +19% | +$2.53M | 0.76% | 43 |
|
|
2018
Q4 | $14.3M | Buy |
218,752
+47,199
| +28% | +$3.52M | 0.92% | 41 |
|
|
2018
Q3 | $13.5M | Buy |
+171,553
| New | +$12.3M | 0.59% | 42 |
|
Other funds holding CVS
Cidel Asset Management's CVS Position: Q2 2026 in Review
Cidel Asset Management reduced its CVS Health (CVS) stake by 3.4% in Q2 2026, selling an estimated $119K and leaving 38,234 shares worth $3.96M. The position accounts for 0.19% of the portfolio, ranked #85.
Cidel Asset Management first reported a position in CVS in Q3 2018 and has held it in 32 quarters since. The position peaked at $39.9M in Q4 2021. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Cidel Asset Management held 38,234 shares of CVS Health worth $3.96M as of Q2 2026.
- Cidel Asset Management sold 1,331 CVS Health shares in Q2 2026, an estimated $119K.
- CVS Health made up 0.19% of Cidel Asset Management's portfolio in Q2 2026, its #85 holding.
- Cidel Asset Management first reported a position in CVS Health in Q3 2018 and has held it in 32 quarters since.
- Cidel Asset Management's CVS Health position peaked at $39.9M in Q4 2021.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Cidel Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.